Advertisement
Advertisement
November 16, 2026
Abbott’s CardioMEMS Hero Reader Approved in Europe
KEY TAKEAWAYS
- Abbott has received CE Mark approval for its CardioMEMS Hero reader for remote heart failure monitoring in Europe.
- The reader works with the CardioMEMS HF system, an implanted pulmonary artery sensor.
- The new reader is 60% lighter than its predecessor and incorporates Wi-Fi and cellular connectivity to support monitoring at home or during travel.
November 16, 2026—Abbott has received CE Mark approval for its CardioMEMS Hero device reader, which is designed to make daily remote heart failure monitoring easier and more convenient for patients.
According to Abbott, Hero is a next-generation component of its CardioMEMS HF system that works with a small sensor implanted in the pulmonary artery to monitor pressure changes that can signal worsening heart failure, often before symptoms appear.
The company stated that the CardioMEMS Hero reader allows patients to transmit daily readings sent from the implanted sensor via the reader to their care teams, helping clinicians identify changes and adjust treatment earlier.
Abbott noted that the reader is designed to improve the functionality and user friendliness of the CardioMems HF system. Hero is 60% lighter than the previous reader and is designed to fit into a carry-on suitcase, for daily monitoring at home or while traveling. Integrated Wi-Fi and cellular connectivity allows patients to take and transmit readings virtually anywhere they have a signal to keep care teams informed between appointments, stated the company.
Advertisement
Advertisement